[
  {
    "ts": null,
    "headline": "Pfizer 2025 Guidance Signals Relief to Investors, UBS Says",
    "summary": "Pfizer's (PFE) initial 2025 guidance signals relief to investors as it highlights stabilizing busine",
    "url": "https://finnhub.io/api/news?id=a52a5703ceaf88387ddc9aba8694938b2b15f420239522c686500b9c2b7b00a1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734552453,
      "headline": "Pfizer 2025 Guidance Signals Relief to Investors, UBS Says",
      "id": 132043987,
      "image": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer's (PFE) initial 2025 guidance signals relief to investors as it highlights stabilizing busine",
      "url": "https://finnhub.io/api/news?id=a52a5703ceaf88387ddc9aba8694938b2b15f420239522c686500b9c2b7b00a1"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer’s Take on Pfizer (PFE): Can CEO Dr. Bourla’s Bold Strategy Overcome Debt and Turn the Stock Around?",
    "summary": "We recently published a list of the Jim Cramer Just Discussed These 13 Stocks. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other stocks that Jim Cramer discussed recently. As the Federal Reserve exits the year by having continued its interest rate cuts, Wall Street is […]",
    "url": "https://finnhub.io/api/news?id=0ff5d624ddc4e401908cb6e0182b2b5efc6f5f2356c4bc88fc21914d21547b29",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734551712,
      "headline": "Jim Cramer’s Take on Pfizer (PFE): Can CEO Dr. Bourla’s Bold Strategy Overcome Debt and Turn the Stock Around?",
      "id": 132043988,
      "image": "https://s.yimg.com/ny/api/res/1.2/EpAz_Vcy0hmyqhi5PSK_ZA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/aef4b35e5ea946bf7f4ed347e5c4f487",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "We recently published a list of the Jim Cramer Just Discussed These 13 Stocks. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other stocks that Jim Cramer discussed recently. As the Federal Reserve exits the year by having continued its interest rate cuts, Wall Street is […]",
      "url": "https://finnhub.io/api/news?id=0ff5d624ddc4e401908cb6e0182b2b5efc6f5f2356c4bc88fc21914d21547b29"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Inc. stock underperforms Wednesday when compared to competitors",
    "summary": "Pfizer Inc. stock underperforms Wednesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=d10d7c09726526f48c3a09d7bf64f610e930fe733b5356c9b5d165320eacdc00",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734539880,
      "headline": "Pfizer Inc. stock underperforms Wednesday when compared to competitors",
      "id": 132066912,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Pfizer Inc. stock underperforms Wednesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=d10d7c09726526f48c3a09d7bf64f610e930fe733b5356c9b5d165320eacdc00"
    }
  },
  {
    "ts": null,
    "headline": "Merck's BLA for RSV Antibody Clesrovimab Gets FDA Acceptance",
    "summary": "The FDA accepts MRK's BLA for clesrovimab, its monoclonal antibody, to protect infants from RSV disease. A decision from the agency is due on June 10, 2025.",
    "url": "https://finnhub.io/api/news?id=70729b4bebfc89b4bc57769762dae1153fe75f01e41c1ab4eaac64a3d88f4fa0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734534000,
      "headline": "Merck's BLA for RSV Antibody Clesrovimab Gets FDA Acceptance",
      "id": 132041330,
      "image": "https://media.zenfs.com/en/zacks.com/1b28b8f55ab25205feceb1a2771a2b3a",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The FDA accepts MRK's BLA for clesrovimab, its monoclonal antibody, to protect infants from RSV disease. A decision from the agency is due on June 10, 2025.",
      "url": "https://finnhub.io/api/news?id=70729b4bebfc89b4bc57769762dae1153fe75f01e41c1ab4eaac64a3d88f4fa0"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Stock Up 5% as 2025 Guidance Meets Investor Expectations",
    "summary": "Pfizer projects total revenues between $61.0 and $64.0 billion with EPS in the range of $2.80 to $3.00.",
    "url": "https://finnhub.io/api/news?id=26b019888235873ad77c65333815fde290731fccb9e86aa2c38f88e53d3651fd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734532980,
      "headline": "Pfizer Stock Up 5% as 2025 Guidance Meets Investor Expectations",
      "id": 132040426,
      "image": "https://media.zenfs.com/en/zacks.com/96776645e0ac7ab203b7d5e3b37251a6",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer projects total revenues between $61.0 and $64.0 billion with EPS in the range of $2.80 to $3.00.",
      "url": "https://finnhub.io/api/news?id=26b019888235873ad77c65333815fde290731fccb9e86aa2c38f88e53d3651fd"
    }
  },
  {
    "ts": null,
    "headline": "Kirk Spano On Bitcoin, Options Selling And A Choppy 2025",
    "summary": "WhyÂ Kirk SpanoÂ has been bullish - and successful - with the market and Bitcoin this year and what he sees for 2025.",
    "url": "https://finnhub.io/api/news?id=f94c6c0d670d3a15de0bf7939ca3605caecdea3e88b8e31832e9c1a865ac0a60",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734527100,
      "headline": "Kirk Spano On Bitcoin, Options Selling And A Choppy 2025",
      "id": 132040303,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1355583079/image_1355583079.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "WhyÂ Kirk SpanoÂ has been bullish - and successful - with the market and Bitcoin this year and what he sees for 2025.",
      "url": "https://finnhub.io/api/news?id=f94c6c0d670d3a15de0bf7939ca3605caecdea3e88b8e31832e9c1a865ac0a60"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, Kennedy",
    "summary": "Pfizer stock is setting up for a wild ride in 2025 as it faces off with an activist and Robert F. Kennedy Jr. as the possible HHS lead.",
    "url": "https://finnhub.io/api/news?id=d1785cd2c484a2d8dba47dffe1904eb40744e036b4ef701e1edd63a6b7d2a07b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734526839,
      "headline": "Pfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, Kennedy",
      "id": 132043991,
      "image": "https://media.zenfs.com/en/ibd.com/f24615fc4389c8c9f2e13b12b28e3ea3",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer stock is setting up for a wild ride in 2025 as it faces off with an activist and Robert F. Kennedy Jr. as the possible HHS lead.",
      "url": "https://finnhub.io/api/news?id=d1785cd2c484a2d8dba47dffe1904eb40744e036b4ef701e1edd63a6b7d2a07b"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Momentum Shift Makes Me Less Bullish (Technical Analysis)",
    "summary": "Pfizer Inc.'s technical indicators have shifted from bullish to bearish, with the stock now trading below its 30-week EMA and showing bearish momentum. Read more here.",
    "url": "https://finnhub.io/api/news?id=750501af75753d0084fb8a24b47ba0d0fdf4d3a0d2505d0032321a3b05ad91c6",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734526355,
      "headline": "Pfizer Momentum Shift Makes Me Less Bullish (Technical Analysis)",
      "id": 132040238,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1491484031/image_1491484031.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Pfizer Inc.'s technical indicators have shifted from bullish to bearish, with the stock now trading below its 30-week EMA and showing bearish momentum. Read more here.",
      "url": "https://finnhub.io/api/news?id=750501af75753d0084fb8a24b47ba0d0fdf4d3a0d2505d0032321a3b05ad91c6"
    }
  },
  {
    "ts": null,
    "headline": "Trending tickers: Pfizer, Micron, Nissan, Teva and National Grid",
    "summary": "The latest investor updates on stocks that are trending on Wednesday.",
    "url": "https://finnhub.io/api/news?id=e9048544d2ad47fdf3b88a2250bd55f775dcea2eb515bf6db394ec4cc732e75c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734523206,
      "headline": "Trending tickers: Pfizer, Micron, Nissan, Teva and National Grid",
      "id": 132039063,
      "image": "https://s.yimg.com/ny/api/res/1.2/nRkD.fY.E0DqzF655tDtqg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://s.yimg.com/os/creatr-uploaded-images/2024-12/d6669a30-bd26-11ef-bdfd-2443dd9a7c0f",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The latest investor updates on stocks that are trending on Wednesday.",
      "url": "https://finnhub.io/api/news?id=e9048544d2ad47fdf3b88a2250bd55f775dcea2eb515bf6db394ec4cc732e75c"
    }
  },
  {
    "ts": null,
    "headline": "The Dow’s Losing Streak Isn’t a Huge Worry for Markets, Why the Fed Is. And 5 Other Things to Know Today.",
    "summary": "Auto giants Nissan and Honda explore a potential merger, what better-than-expected retail sales mean for the Fed, and more news to start your day.",
    "url": "https://finnhub.io/api/news?id=dc2fc64383148364ff21859fe3a7fb0da8fba3243623af2779b5a57c1cffe97b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734522240,
      "headline": "The Dow’s Losing Streak Isn’t a Huge Worry for Markets, Why the Fed Is. And 5 Other Things to Know Today.",
      "id": 132043993,
      "image": "https://media.zenfs.com/en/Barrons.com/12ea0f43d8f8307249a68d1cb2e0587e",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Auto giants Nissan and Honda explore a potential merger, what better-than-expected retail sales mean for the Fed, and more news to start your day.",
      "url": "https://finnhub.io/api/news?id=dc2fc64383148364ff21859fe3a7fb0da8fba3243623af2779b5a57c1cffe97b"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Pflash: A Spotlight on Clostridioides difficile (C. diff) Vaccine Development Presentation",
    "summary": "Pfizer Pflash: A Spotlight on Clostridioides difficile Vaccine Development Presentation intended for 1 ...",
    "url": "https://finnhub.io/api/news?id=17bb070c48b920c482fccb47288c348cf7f0dd78d3cc4b207bd5f284c50a8df1",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734521652,
      "headline": "Pfizer Pflash: A Spotlight on Clostridioides difficile (C. diff) Vaccine Development Presentation",
      "id": 132039736,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "Pfizer Pflash: A Spotlight on Clostridioides difficile Vaccine Development Presentation intended for 1 ...",
      "url": "https://finnhub.io/api/news?id=17bb070c48b920c482fccb47288c348cf7f0dd78d3cc4b207bd5f284c50a8df1"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer: I'm Short-Term Skeptical, Long-Term Positive Post 2025 Guidance Call",
    "summary": "Pfizerâs financial challenges are offset by growth potential in oncology and strong dividends. Learn why PFE stock is a \"Buy\" as we look toward 2025.",
    "url": "https://finnhub.io/api/news?id=8f79def61af3be1708e5b903db4bf9729d73b4b340f50bbbac83940c1eaa95c5",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734521024,
      "headline": "Pfizer: I'm Short-Term Skeptical, Long-Term Positive Post 2025 Guidance Call",
      "id": 132039689,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2178153244/image_2178153244.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Pfizerâs financial challenges are offset by growth potential in oncology and strong dividends. Learn why PFE stock is a \"Buy\" as we look toward 2025.",
      "url": "https://finnhub.io/api/news?id=8f79def61af3be1708e5b903db4bf9729d73b4b340f50bbbac83940c1eaa95c5"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer : Analyst and Investor Call to Review Pfizer Full-Year 2025 Financial Guidance Transcript",
    "summary": "REFINITIV STREETEVENTS EDITED TRANSCRIPT PFE.N - Pfizer Inc to Host Full-Year 2025 Guidance Call EVENT DATE/TIME:...",
    "url": "https://finnhub.io/api/news?id=5e8cee31029d92fc971fc54926f79ff179972a2fee1040ddb20d5dac935cbf37",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734516245,
      "headline": "Pfizer : Analyst and Investor Call to Review Pfizer Full-Year 2025 Financial Guidance Transcript",
      "id": 132039225,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "REFINITIV STREETEVENTS EDITED TRANSCRIPT PFE.N - Pfizer Inc to Host Full-Year 2025 Guidance Call EVENT DATE/TIME:...",
      "url": "https://finnhub.io/api/news?id=5e8cee31029d92fc971fc54926f79ff179972a2fee1040ddb20d5dac935cbf37"
    }
  },
  {
    "ts": null,
    "headline": "3 of the Safest Ultra-High-Yield Dividend Stocks to Buy in 2025",
    "summary": "These top-tier income stocks are sporting an average yield of 8.53%!",
    "url": "https://finnhub.io/api/news?id=01e734e8bdb110371e3b04e964a1d9fd9006e3a8ac256c66348a761bc820003b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734515460,
      "headline": "3 of the Safest Ultra-High-Yield Dividend Stocks to Buy in 2025",
      "id": 132041620,
      "image": "https://g.foolcdn.com/editorial/images/801116/person-holding-cash-bills-money-hundred-dollar-fifty-dividend-income-invest-retire-spend-getty.jpg",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "These top-tier income stocks are sporting an average yield of 8.53%!",
      "url": "https://finnhub.io/api/news?id=01e734e8bdb110371e3b04e964a1d9fd9006e3a8ac256c66348a761bc820003b"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer: Jefferies confirms its analysis on the stock",
    "summary": "Jefferies maintains its Buy rating on Pfizer shares, with an unchanged price target of $33. The analyst reports that the 2025 forecasts delivered by the laboratory have exceeded his and the market's...",
    "url": "https://finnhub.io/api/news?id=23aeaf0820e4f5680160cfcb328f41ef8fcd5bb41a64d13ccaa4708e776bbf48",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734512171,
      "headline": "Pfizer: Jefferies confirms its analysis on the stock",
      "id": 132038783,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "Jefferies maintains its Buy rating on Pfizer shares, with an unchanged price target of $33. The analyst reports that the 2025 forecasts delivered by the laboratory have exceeded his and the market's...",
      "url": "https://finnhub.io/api/news?id=23aeaf0820e4f5680160cfcb328f41ef8fcd5bb41a64d13ccaa4708e776bbf48"
    }
  },
  {
    "ts": null,
    "headline": "My Dividend Stock Portfolio: New November Dividend Record - 97 Holdings With 18 Buys",
    "summary": "Financial writer achieves record dividend income in November through investments in BDCs, inching closer to $10,000 annual goal.",
    "url": "https://finnhub.io/api/news?id=1622bfcd6476b1f6935d84f1ad53065555594e875fe18e2d92fb59ae55233c0a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734509400,
      "headline": "My Dividend Stock Portfolio: New November Dividend Record - 97 Holdings With 18 Buys",
      "id": 132038523,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1213764535/image_1213764535.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Financial writer achieves record dividend income in November through investments in BDCs, inching closer to $10,000 annual goal.",
      "url": "https://finnhub.io/api/news?id=1622bfcd6476b1f6935d84f1ad53065555594e875fe18e2d92fb59ae55233c0a"
    }
  },
  {
    "ts": null,
    "headline": "Big Pharma’s new DTC play: partnering with digital health providers",
    "summary": "The pharma giant is looking for another edge in the competitive weight loss market through DTC expansion.",
    "url": "https://finnhub.io/api/news?id=b040070ac9cd5ed610783d773743a0ec5fa1dfb8cca2a202d7124160fec4e76d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734507560,
      "headline": "Big Pharma’s new DTC play: partnering with digital health providers",
      "id": 132039124,
      "image": "https://imgproxy.divecdn.com/7RQWbb4vOgXkLincF6pxOGRRVc-yrwvglzJqowSC1zE/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMDkyNDgxMzQwX3kzQ1NFUFguanBn.webp",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The pharma giant is looking for another edge in the competitive weight loss market through DTC expansion.",
      "url": "https://finnhub.io/api/news?id=b040070ac9cd5ed610783d773743a0ec5fa1dfb8cca2a202d7124160fec4e76d"
    }
  }
]